487 related articles for article (PubMed ID: 29414663)
1. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
2. Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.
Mu N; Lin F; Jiang Z; Liang Y; Yang Z
Immunol Invest; 2021 Aug; 50(6):662-670. PubMed ID: 32613870
[TBL] [Abstract][Full Text] [Related]
3. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
4. Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis.
Lin F; Shi H; Liu D; Zhang Z; Luo W; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2019 Feb; 67():372-377. PubMed ID: 30583236
[TBL] [Abstract][Full Text] [Related]
5. Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay.
Wang Z; Li Y; Ren L; Li Y; Xu T; Li W; Gao W; Sun G; Liu M
Immun Inflamm Dis; 2024 Jan; 12(1):e1161. PubMed ID: 38270327
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
7. Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients.
Zhang Y; Shi Y; Wu R; Wang X; Gao X; Niu J
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):682-686. PubMed ID: 29462025
[TBL] [Abstract][Full Text] [Related]
8. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis.
Jiang X; Wang Y; Su Z; Yang F; Lv H; Lin L; Sun C
Scand J Clin Lab Invest; 2018 Jul; 78(4):258-263. PubMed ID: 29533114
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature.
de Liso F; Matinato C; Ronchi M; Maiavacca R
Clin Chem Lab Med; 2017 Nov; 56(1):25-31. PubMed ID: 28731850
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis.
Villalta D; Seaman A; Tiongson M; Warren C; Bentow C; Bizzaro N; Alessio MG; Porcelli B; Norman GL; Mahler M
Clin Chem Lab Med; 2020 Aug; 58(9):1499-1507. PubMed ID: 32286240
[TBL] [Abstract][Full Text] [Related]
13. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
14. The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis.
Shi T; Zhang T; Zhang L; Yang Y; Zhang H; Zhang F
Medicine (Baltimore); 2015 Nov; 94(44):e1888. PubMed ID: 26554784
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
Liu ZY; Xu L; Liu B
Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
[TBL] [Abstract][Full Text] [Related]
16. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
17. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
18. [The effect of Cathepsin S in primary biliary cholangitis].
Luo X; Li X; Du ZR; Peng Y; Deng CW; Fei YY
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):505-509. PubMed ID: 30786347
[No Abstract] [Full Text] [Related]
19. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis.
Wang H; Xu H; Wang X; Wu R; Gao X; Jin Q; Niu J
Medicine (Baltimore); 2016 Mar; 95(11):e3114. PubMed ID: 26986159
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.
Li Y; Li B; You Z; Zhang J; Wei Y; Li Y; Chen Y; Huang B; Wang Q; Miao Q; Peng Y; Fang J; Gershwin ME; Tang R; Greenberg SA; Ma X
J Autoimmun; 2019 Sep; 103():102293. PubMed ID: 31255417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
